ProRx Pharma, the leading health and wellness 503B outsourcing facility, today announced a period of significant growth, including increased production capacity, a larger facility footprint, and expanded delivery capabilities into two new states, Oklahoma and Virginia, with additional states expected in the coming months. Read More >
ProRx Pharma is an FDA-registered 503B facility focused on providing essential compounded sterile and non-sterile preparations. The company compounds products and formulations for medical institutions, physician offices, and 503A pharmacies, with a specialization in producing high-quality products to ensure patients have access to the medications they need during critical shortages.
This post is related to:
